Clinical trial

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer

NCT00854789

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention E75 + GM-CSF vaccine Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-12-01

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

E75 + GM-CSF vaccineBIOLOGICAL

Sponsors & collaborators

COL George Peoples, MD, FACSlead sponsor

Uniformed Services University of the Health Sciencescollaborator

Mapped research locations

Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00854789 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.